ICAN vs HHS, Vaccine Table Injuries, Pediatrician Vax Push Back, Higher Dose Wegovy Approved, Allergy Season Protection Tips, Brachyglottis Repens, Can Homeopathy Make You Healthy, Safer Screening, Religion Decline Anxiety, and MORE!

Mar 24, 2026 3-5pm ET

Tuesday on The Robert Scott Bell Show:

Hour 1

ICAN Petition Urges HHS and RFK Jr. to Add Injuries to Vaccine Injury Table The Informed Consent Action Network (ICAN) has submitted a formal petition to the U.S. Department of Health and Human Services and Secretary Robert F. Kennedy Jr. requesting the immediate addition of several serious conditions to the Vaccine Injury Table, the official list that determines presumptive compensation eligibility under the National Childhood Vaccine Injury Act, arguing that current omissions force injured families to prove causation in an already adversarial and underfunded system, delaying or denying justice for conditions with strong temporal and biological links to vaccination that are well-documented in VAERS reports, peer-reviewed studies, and clinical observations. ICAN specifically asks for inclusion of myocarditis/pericarditis (particularly following mRNA COVID-19 and other vaccines), Guillain-Barré syndrome, transverse myelitis, encephalopathy/encephalitis, chronic inflammatory demyelinating polyneuropathy, anaphylaxis beyond the current narrow window, autoimmune disorders including autoimmune hepatitis and type 1 diabetes in susceptible individuals, and sudden infant death syndrome (SIDS) when occurring within a defined post-vaccination period, citing extensive evidence of biological plausibility through molecular mimicry, adjuvant-induced immune activation, and blood-brain barrier disruption. The petition emphasizes that the existing Vaccine Injury Table has not been meaningfully updated since the 1990s for most conditions, despite dramatic expansion of the childhood vaccine schedule and thousands of compensation awards already granted by the Vaccine Court for injuries not listed on the table, which requires petitioners to meet a higher evidentiary burden and often results in lower or denied payouts. ICAN argues that adding these injuries would streamline compensation, reduce legal costs, provide faster relief to families, and restore fairness to a system originally intended as a no-fault alternative to litigation that has increasingly functioned as a barrier to accountability for manufacturers shielded by the 1986 Act. The organization also requests that HHS establish a transparent, science-based process for regular table updates based on VAERS signals, published literature, and expert review rather than relying on slow, politically influenced revisions. Kennedy has previously expressed support for reforming the compensation program and increasing transparency around vaccine injuries, making the petition timely as his department reevaluates federal vaccine policy. The article frames the petition as part of a broader push for accountability, informed consent, and recognition of vaccine injuries as a legitimate public health issue rather than rare coincidences, urging supporters to contact HHS and their representatives to demand prompt action on the requested table expansions to ensure injured children and adults receive timely and adequate support.

Pediatricians Push Back Against RFK Jr.’s Vaccine Changes The American Academy of Pediatrics (AAP) and several leading pediatric medical organizations issued a strongly worded joint statement on March 12, 2026, condemning recent changes to federal vaccine recommendations under Health and Human Services Secretary Robert F. Kennedy Jr., including the narrowing of routine childhood immunizations and the shift of COVID-19 vaccination to shared clinical decision-making rather than universal guidance, arguing that these alterations undermine decades of public health progress, threaten herd immunity, and place children at unnecessary risk of preventable diseases such as measles, pertussis, and hepatitis B. The statement, signed by the AAP, the Pediatric Infectious Diseases Society, the Society for Maternal-Fetal Medicine, and other groups, accuses the reconstituted Advisory Committee on Immunization Practices (ACIP) of prioritizing ideology over evidence by dismissing established safety and efficacy data, failing to follow transparent scientific processes, and introducing bias through the appointment of members perceived as vaccine-skeptical. Pediatricians expressed particular concern over reduced recommendations for the newborn hepatitis B vaccine and COVID-19 shots for healthy children, warning that lowered coverage could lead to increased outbreaks, hospitalizations, and deaths in vulnerable pediatric populations, especially infants too young for full immunization and immunocompromised children. The AAP emphasized that current schedules have dramatically reduced morbidity and mortality from vaccine-preventable diseases and that any changes should be based on rigorous, peer-reviewed science rather than political considerations. The statement urges pediatricians to continue following pre-2025 ACIP recommendations in clinical practice until the legal challenges and policy debates are resolved, while calling on Congress to intervene and restore evidence-based federal guidance. Kennedy’s office responded that the adjustments reflect a commitment to individualized risk-benefit assessment, greater transparency in safety monitoring, and a focus on addressing chronic disease drivers rather than over-reliance on pharmaceutical interventions, asserting that parents and physicians should make informed decisions tailored to each child’s health status rather than adhering to one-size-fits-all mandates. The controversy highlights deepening divisions between established pediatric organizations and the Make America Healthy Again agenda, with ongoing litigation in federal court challenging the legality of the ACIP reconstitution and recent votes. The AAP and allies have filed suit seeking to invalidate post-reconstitution decisions and reinstate prior members or guidance, arguing procedural violations and potential public health harm from declining vaccination rates. The article notes that while some parents and health freedom advocates welcome the changes as empowering choice and scrutiny of pharmaceutical influence, mainstream pediatricians fear the policy shifts could reverse hard-won gains in child health and increase preventable illness in communities with already uneven coverage.

FDA Approves Higher Dose Wegovy to Help People Lose More Weight The U.S. Food and Drug Administration on March 23, 2026, approved a higher-dose version of Wegovy (semaglutide) for chronic weight management, allowing patients to escalate up to 7.2 mg weekly—significantly above the previously approved maximum of 2.4 mg—after clinical trials showed additional weight loss of approximately 5–7% beyond standard dosing in adults with obesity or overweight with weight-related conditions, while maintaining a similar safety profile to the existing formulation. The approval was based on a 72-week Phase 3 trial involving over 1,300 participants who had already lost weight on the 2.4 mg dose and were then randomized to continue standard dosing or escalate to 7.2 mg, with the higher-dose group achieving an average additional 6.2% body weight reduction compared to 1.8% in the control arm, translating to roughly 15–20 pounds of extra loss for many participants on top of the 15–20% total weight reduction typically seen with standard Wegovy. Novo Nordisk, the manufacturer, stated the higher dose will be available in a new titration schedule starting at 0.25 mg and gradually increasing to 7.2 mg over several months to minimize gastrointestinal side effects, which remain the most common reason for discontinuation. The FDA label update includes warnings for the same known risks associated with GLP-1 receptor agonists, including nausea, vomiting, diarrhea, constipation, gallbladder disease, pancreatitis, and rare but serious concerns such as thyroid C-cell tumors (observed in rodents) and potential increased risk of suicidal ideation, with the agency requiring continued post-marketing surveillance for long-term cardiovascular and psychiatric outcomes. Experts welcomed the option for patients who plateau on standard dosing but cautioned that the higher dose may not be suitable for everyone, particularly those with gastrointestinal sensitivity or history of thyroid disease, and emphasized that the medication works best when combined with intensive lifestyle changes including diet, exercise, and behavioral support. The approval comes amid surging demand for GLP-1 drugs and ongoing debate over their long-term safety, cost-effectiveness, and potential for muscle loss during rapid weight reduction. Insurance coverage for the higher dose remains uncertain, with many plans currently limiting approval to the 2.4 mg strength or requiring step therapy. The article notes that while the higher dose may help patients achieve greater weight loss and metabolic benefits, real-world adherence and sustained results after discontinuation remain challenges, with many patients regaining substantial weight when stopping therapy. The FDA’s decision reflects continued expansion of the GLP-1 class for obesity treatment, with analysts projecting the higher-dose Wegovy could further boost Novo Nordisk’s already massive revenue from the drug while intensifying scrutiny over long-term risks and the need for lifestyle interventions to maintain benefits.

Allergy Season: How to Protect Yourself This Year With allergy season already underway in many parts of the U.S. and expected to be particularly intense in 2026 due to an early warm spring, higher pollen counts driven by climate trends, and lingering effects from last year’s record pollen season, health experts are urging people to prepare now with a combination of avoidance strategies, over-the-counter medications, and lifestyle adjustments to minimize symptoms such as sneezing, itchy eyes, runny nose, congestion, and fatigue that affect tens of millions of Americans each year. The American College of Allergy, Asthma and Immunology and the Asthma and Allergy Foundation of America recommend starting daily non-sedating antihistamines (such as loratadine, cetirizine, or fexofenadine) 1–2 weeks before peak pollen seasons for those with known allergies, using corticosteroid nasal sprays (fluticasone, mometasone) for congestion, and keeping windows closed while using HEPA air filters and air conditioning to reduce indoor pollen exposure. Additional practical steps include showering and changing clothes after being outdoors to remove pollen, washing bedding weekly in hot water, avoiding outdoor activities during high-pollen hours (typically mid-morning to early evening), and wearing sunglasses and hats to protect eyes and hair from pollen grains. For more severe cases, allergists may recommend allergen immunotherapy (allergy shots or sublingual tablets) that can provide long-term relief by desensitizing the immune system, with new biologic medications like dupilumab offering targeted relief for those with severe allergic rhinitis or comorbid asthma. Experts note that climate change is extending pollen seasons and increasing pollen potency in many regions, with ragweed, tree pollen, and grass pollen peaks overlapping more than in previous decades, leading to longer periods of misery for sufferers. The article stresses that while over-the-counter remedies help most people, those with asthma or other respiratory conditions should consult a doctor promptly if symptoms worsen, as allergies can trigger asthma exacerbations. It also warns against unproven remedies such as local honey (which does not reliably reduce pollen allergies) and emphasizes evidence-based approaches over social media trends. With pollen counts already elevated in the South and Southeast and expected to rise rapidly in the Midwest and Northeast as temperatures warm, the message from allergists is clear: proactive management starting now can significantly reduce symptoms and improve quality of life during what may be another challenging allergy season.

Welcome back to another “Homeopathic Hits” episode on The Robert Scott Bell Show!

Today’s Homeopathic Hit is Brachyglottis Repens, also known as Puka-Puka.

Boericke presents this remedy as acting prominently on the kidneys and bladder, producing symptoms of albuminuria and Bright’s disease, along with urinary irritation and nervous manifestations such as writer’s cramp.

Download the  Information Sheet

Hour 2

Can Homeopathy Make You Healthy Again? Homeopathy, a 200-year-old system of medicine based on the principle of “like cures like” and the use of highly diluted substances to stimulate the body’s self-healing response, is gaining renewed attention within the Make America Healthy Again (MAHA) movement as a potential low-cost, non-toxic complement or alternative to conventional pharmaceutical approaches for treating chronic conditions, acute illnesses, and vaccine-related injuries, with growing numbers of patients and practitioners reporting positive outcomes where mainstream treatments have fallen short. The article explores how homeopathic remedies—prepared through serial dilution and succussion (vigorous shaking) to create ultra-high dilutions often beyond Avogadro’s number, theoretically containing only the energetic imprint of the original substance—have been used successfully for conditions ranging from allergies, eczema, asthma, and migraines to anxiety, depression, and post-vaccination syndromes, with proponents arguing that the remedies work by gently stimulating the vital force rather than suppressing symptoms or introducing foreign chemicals that may cause side effects or dependency. Anecdotal and observational reports from MAHA-aligned practitioners and patients describe rapid resolution of symptoms in children with behavioral issues, adults with autoimmune flares, and individuals experiencing lingering effects from COVID-19 vaccines or other medications, often without the adverse reactions associated with conventional drugs. The piece acknowledges the scientific controversy surrounding homeopathy, noting that critics dismiss it as placebo due to the extreme dilutions and lack of large-scale randomized controlled trials meeting conventional standards, while supporters point to a substantial body of clinical outcome studies, meta-analyses, and basic research on water structure and electromagnetic signaling that suggest mechanisms beyond simple placebo, including potential effects on gene expression, inflammation pathways, and autonomic nervous system balance. Within the MAHA framework, homeopathy is presented as aligning with principles of minimal intervention, individualized treatment, and respect for the body’s innate healing capacity, offering an affordable option that reduces reliance on expensive pharmaceuticals and their associated risks. The article highlights growing interest among parents seeking gentler approaches for childhood illnesses, chronic disease patients looking for adjunctive care, and individuals recovering from iatrogenic harm, with calls for more research funding, integration into integrative clinics, and protection of homeopathic practitioners from regulatory overreach by medical boards favoring allopathic models. Kennedy has not formally endorsed homeopathy but has emphasized openness to safe, effective, and individualized therapies that address root causes rather than symptoms, creating space for broader discussion of non-conventional modalities within federal health policy. The piece concludes that while homeopathy may not replace emergency or surgical care, it deserves serious consideration as part of a diversified, patient-centered healthcare system focused on true healing and prevention rather than perpetual disease management.

Religion Declines, Child Anxiety Rises A significant decline in religious participation and belief among American families over the past two decades has coincided with a sharp rise in anxiety, depression, and related mental health issues among children and adolescents, according to a comprehensive analysis published in the journal Psychological Medicine that examined data from multiple large-scale national surveys including the Monitoring the Future study, the National Survey of Children’s Health, and the Pew Research Center’s religious landscape studies spanning 2005 to 2025. The research found that the percentage of U.S. households reporting regular religious service attendance dropped from 42% in 2005 to 24% in 2025, while the proportion of children raised with no religious affiliation increased from 12% to 38% over the same period, trends that strongly correlated with rising rates of diagnosed anxiety disorders (from 5.5% to 15.2%) and depressive symptoms (from 8.7% to 18.4%) among youth aged 6–17, even after adjusting for socioeconomic status, family structure, screen time, academic pressure, and access to mental health services. The study identified several mechanisms potentially linking declining religiosity to increased childhood anxiety: religious communities often provide social support networks, moral frameworks, and coping strategies that buffer stress; shared rituals and beliefs foster a sense of meaning, purpose, and belonging that mitigate existential anxiety; and religious upbringing is associated with lower rates of adverse childhood experiences and higher parental involvement in moral and emotional development. Children from non-religious households showed higher cortisol levels, greater rumination on negative events, and reduced resilience to setbacks, with the effect most pronounced in early adolescence when identity formation and peer pressure intensify. The authors note that while causation cannot be definitively established from observational data, the consistent temporal and dose-response patterns—families with complete loss of religious practice showed the highest anxiety rates, while those maintaining regular involvement had rates closer to historical norms—suggest a meaningful association warranting further investigation. The findings add to a growing body of research linking secularization trends with mental health challenges, particularly among youth, and raise questions about whether the erosion of traditional sources of meaning, community, and moral guidance has left a psychological void increasingly filled by social media, consumerism, and therapeutic culture that may exacerbate rather than resolve underlying distress. The article calls for greater awareness among parents, educators, and mental health professionals of the protective role that religious or spiritual frameworks can play, while acknowledging that non-religious families can foster resilience through strong community ties, purpose-driven activities, and open discussions of values and meaning. Researchers emphasize the need for balanced approaches that respect diverse worldviews while addressing the mental health consequences of rapid cultural shifts away from organized religion in American society.

Remember Friends, The Power to Heal is Yours!